Philips Medical Systems International apparently made a good impressionon visiting Chinese physicians during the 1990 Radiological Societyof North America conference. Authorities in the People's Republicof China ordered a second Philips T5 mid-field
Philips Medical Systems International apparently made a good impressionon visiting Chinese physicians during the 1990 Radiological Societyof North America conference. Authorities in the People's Republicof China ordered a second Philips T5 mid-field magnetic resonanceimaging scanner last month. The first T5 unit is scheduled fordelivery in May.
The Chinese do not express much interest in low-field MRI,said Ron F. Jongbloets, PMSI regional manager for China, HongKong and Southeast Asia. They are looking for mid-field scannersto operate in regular hospitals and high-field systems for universityfacilities, he said.
A research group of Chinese university-affiliated doctors selectedthe T5 as the best mid-field MRI system during the RSNA meetinglast November in Chicago, Jongbloets said.
The two MRI orders mark an important initial step for PMSIin the PRC. Philips has no MRI systems installed in that country,although eight of its computed tomography units are installed,Jongbloets said.
The MRI market is in its infancy in China. There are only about10 systems overall in the country, compared to about 300 CT scanners,he said.
The Chinese hope to develop indigenous MRI manufacturing capabilities.They already produce low-field 0.15-tesla permanent magnet MRIunits through a joint venture with Analogic of the U.S. (SCAN12/14/88), Jongbloets said.
PRC officials are also interested in producing 0.5-tesla MRIsystems. Philips is exploring possible forms of cooperation insuch an endeavor, he said.
Chinese authorities only release enough foreign exchange tofinance the importation of four MRI systems a year. PMSI has beenable to deal directly with hospitals, although central permissionis required for high-value medical equipment purchases, he said.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.